Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
IMHO, ARM is behind PubPat act. They're throwing them into the mix. It's all just smoke screen and a desperation move by J3/ARM. I don't buy into this for one bit. If they were holding onto a wining hand in terms of prior art, why wait until this point?. Time is runing and sense of desperation is setting in. Time will tell.
